Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 known ✓ | O95136 | 2/20 | 0.31 |
| ▸ | S1PR4 known ✓ | O95977 | 2/20 | 0.31 |
| ▸ | S1PR1 known ✓ | P21453 | 2/20 | 0.31 |
| ▸ | S1PR3 known ✓ | Q99500 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KDM4A | O75164 | 1/20 | 0.33 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.33 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.32 |
| ▸ | UBE2N | P61088 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10703373 | 0.93 | LMNA (0.39) | LMNAALDH1A1HTTATMNPSR1 | |
| Hydrochloric Acid SCHEMBL8619893 | 0.91 | ALDH1A1 (0.41) | LMNAALDH1A1KDM4CTSHRKDM4A | |
| SCHEMBL27684888 | 0.89 | ALDH1A1 (0.42) | LMNAALDH1A1KDM4CTSHRKDM4A | |
| SCHEMBL7754958 | 0.89 | ALDH1A1 (0.42) | LMNAALDH1A1KDM4CTSHRKDM4A | |
| SCHEMBL11474572 | 0.89 | ALDH1A1 (0.42) | LMNAALDH1A1KDM4CTSHRKDM4A | |
| SCHEMBL28467631 | 0.89 | ALDH1A1 (0.42) | LMNAALDH1A1KDM4CTSHRKDM4A | |
| SCHEMBL11452986 | 0.89 | ALDH1A1 (0.42) | LMNAALDH1A1KDM4CTSHRKDM4A | |
| SCHEMBL10606570 | 0.89 | ALDH1A1 (0.42) | LMNAALDH1A1KDM4CTSHRKDM4A | |
| Hydrochloric Acid SCHEMBL9494319 | 0.89 | LMNA (0.46) | LMNAALDH1A1KDM4CTSHRKDM4A | |
| SCHEMBL11464311 | 0.86 | ALDH1A1 (0.40) | LMNAALDH1A1KDM4CTSHRKDM4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 563 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3894015-B1 | SHAMPOO COMPOSITION COMPRISING SHEET-LIKE MICROCAPSULES | PROCTER & GAMBLE (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-4103335-B1 | BOTTLE ADAPTED FOR STORING A LIQUID COMPOSITION WITH AN AESTHETIC DESIGN SUSPENDED THEREIN | PROCTER & GAMBLE (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-3663384-B1 | PARTICULATE LAUNDRY SOFTENING WASH ADDITIVE | PROCTER & GAMBLE (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-3727323-B1 | CLEAR SHAMPOO COMPOSITION CONTAINING SILICONE POLYMERS | PROCTER & GAMBLE (US) | 2026-04-29 | — | — | EP | disclosed |
| EP-4729046-A2 | COMPOSITIONS HAVING ENHANCED DEPOSITION OF SURFACTANT SOLUBLE ANTIDANDRUFF AGENTS | The Procter & Gamble Company (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4337333-B1 | SHAMPOO COMPOSITION | PROCTER & GAMBLE (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4171483-B1 | DISSOLVABLE SOLID FIBROUS ARTICLES CONTAINING ANIONIC SURFACTANTS | PROCTER & GAMBLE (US) | 2026-04-08 | — | — | EP | disclosed |
| EP-4349950-B1 | FABRIC CARE COMPOSITION | PROCTER & GAMBLE (US) | 2026-03-25 | — | — | EP | disclosed |
| US-12576013-B2 | Dissolvable solid fibrous shampoo articles containing salts | THE PROCTER & GAMBLE COMPANY (US) | 2026-03-17 | — | — | US | disclosed |
| EP-3784352-B1 | COMPOSITIONS HAVING ENHANCED DEPOSITION OF SURFACTANT SOLUBLE ANTIDANDRUFF AGENTS | PROCTER & GAMBLE (US) | 2026-03-11 | — | — | EP | disclosed |
| WO-2006113658-A2 | DILUTE FABRIC CARE COMPOSITIONS COMPRISING THICKENERS AND FABRIC CARE COMPOSITIONS FOR USE IN THE PRESENCE OF ANIONIC CARRY-OVER | THE PROCTER & GAMBLE COMPANY (US) | 2006-10-26 | — | — | WO | disclosed |
| WO-2006063092-A1 | FABRIC ENHANCING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2006-06-15 | — | — | WO | disclosed |
| US-20060122094-A1 | Fabric enhancing composition | PROCTER & GAMBLE COMPANY, THE | 2006-06-08 | — | — | US | disclosed |
| WO-2006044875-A1 | CONCENTRATED FABRIC SOFTENER ACTIVE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2006-04-27 | — | — | WO | disclosed |
| US-20060089293-A1 | Concentrated fabric softener active compositions | PROCTER & GAMBLE COMPANY, THE | 2006-04-27 | — | — | US | disclosed |
| WO-2006014416-A1 | PERSONAL CARE COMPOSITIONS CONTAINING CATIONICALLY MODIFIED STARCH AND AN ANIONIC SURFACTANT SYSTEM | THE PROCTER & GAMBLE COMPANY (US) | 2006-02-09 | — | — | WO | disclosed |
| US-20060002880-A1 | Personal care compositions containing cationically modified starch and an anionic surfactant system | THE PROCTER & GAMBLE COMPANY | 2006-01-05 | — | — | US | disclosed |
| EP-1606373-A1 | FABRIC CARE COMPOSITIONS COMPRISING CATIONIC STARCH | THE PROCTER & GAMBLE COMPANY (US) | 2005-12-21 | — | — | EP | disclosed |
| US-20040204337-A1 | Fabric care compositions comprising cationic starch | THE PROCTER & GAMBLE COMPANY | 2004-10-14 | — | — | US | disclosed |
| WO-2004087854-A1 | FABRIC CARE COMPOSITIONS COMPRISING CATIONIC STARCH | THE PROCTER & GAMBLE COMPANY (US) | 2004-10-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060002880-A1 | Personal care compositions containing cationically modified starch and an anionic surfactant system | CUTA, SGMS1, SGMS2 | S1PR2 82/4885S1PR4 138/4885S1PR1 61/4885 |
| US-12576013-B2 | Dissolvable solid fibrous shampoo articles containing salts | SLC6A5, GLUL, SLC6A1 | S1PR2 300/4885S1PR4 503/4885S1PR1 362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.